Skip to content
10-Q

Quarterly Report

Phathom Pharmaceuticals, Inc. PHAT

0000950170-25-061440

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 29, 2025 69.81M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $203.25M
Long Term Debt Q1 2025 · Dec 31, 2024 $201.41M
Short Term Debt Q1 2025 · Mar 31, 2025 $0
Short Term Debt Q1 2025 · Dec 31, 2024 $0
Cash And Equivalents Q1 2025 · Mar 31, 2025 $212.32M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $297.26M
Current Liabilities Q1 2025 · Mar 31, 2025 $74.03M
Current Liabilities Q1 2025 · Dec 31, 2024 $85.73M
Total Liabilities Q1 2025 · Mar 31, 2025 $632.58M
Total Liabilities Q1 2025 · Dec 31, 2024 $631.9M
Current Assets Q1 2025 · Mar 31, 2025 $264.9M
Current Assets Q1 2025 · Dec 31, 2024 $360.13M
Total Assets Q1 2025 · Mar 31, 2025 $294.21M
Total Assets Q1 2025 · Dec 31, 2024 $378.32M